Saturday 17 October 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024. In the quarter to June 2026, revenue grew 66.9%, EPS grew 341.2%, free cash flow grew 152.8% and total debt fell 1.51%, each against the same quarter a year earlier. Member of the Nasdaq 100; revenue growth for five consecutive years.

231.83 2.20 −0.94%

Follow ALNY

Alert me

Market cap: $31.3B
P/E: 39.5×
Fwd P/E: 39.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	6	7	7
ROE Full definition →		57.72%	73.28%	90.36%	96.55%
ROA Full definition →		1.70%	6.82%	11.52%	15.30%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		2.65%	10.13%	15.88%	21.16%
Average Days of Receivables Full definition →		109.70	76.42	75.26	69.35
Free Cash Flow per Share Full definition →		1.68	3.55	4.84	6.14
Free Cash Flow Full definition →		221.36	465.38	643.34	819.87
Capital Expenditures Full definition →		(44.50)	(58.70)	(71.56)	(91.95)
Other line items
Cash ROIC Full definition →		5.54%	9.89%	12.63%	14.45%
Accounts Receivable Turnover Full definition →		4.87	6.28	6.59	6.49
Accounts Payable Turnover Full definition →		5.49	6.68	7.34	9.29
Inventory Turnover Full definition →		6.83	8.46	10.99	11.58
Average Days of Payables Full definition →		83.02	61.94	56.23	40.34
Days of Inventory on Hand Full definition →		53.22	44.28	37.31	36.26
Tax Rate Full definition →		56.60	(0.03)	(0.02)	0.01
Research and Development Expense of Revenue Full definition →		38.87%	35.54%	33.11%	31.41%
Selling, General and Administrative Expense of Revenue Full definition →		36.78%	32.60%	30.17%	27.43%
Share Based Compensation of Revenue Full definition →		11.47%	9.38%	8.44%	7.01%
Interest Coverage Full definition →		1.30	1.99	2.85	3.52
Operating CF/Net income Full definition →		3.46	1.67	1.33	1.18
Depreciation/Fixed assets Full definition →		0.11	0.11	0.11	0.10
Capex/Depreciation Full definition →		(0.79)	(1.05)	(1.31)	(1.68)
Revenue per Share Full definition →		24.42	28.35	32.26	35.96
Operating CF per Share Full definition →		2.02	4.00	5.38	6.82
Capex per Share Full definition →		(0.34)	(0.45)	(0.54)	(0.69)
Capex to Sales Full definition →		0.01	0.02	0.02	0.02

Show all line items

Columns are period end dates

Stockrow Weekly